No definition available.
Interstitial emphysema and related conditions originating in the perinatal period
P16_INTERSTITIAL_EMPHY_RELATED_COND_ORIGINA_PERINA_PERIOD
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
54 |
4. Check minimum number of eventsNone |
54 |
5. Include endpointsNone |
54 |
6. Filter based on genotype QC (FinnGen only) |
54 |
Control definitions (FinnGen only)
- Control exclude
- P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P2
- Name in latin
- Syndromata pulmonum rimosorum origine perinatalia
Similar endpoints
↥List of similar endpoints to
Interstitial emphysema and related conditions originating in the perinatal period
based on the number of shared cases.
Similar with more cases:
- Respiratory and cardiovascular disorders specific to the perinatal period
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4158 | 1500 | 2658 |
| Only index persons | 1854 | 652 | 1202 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.04 | 0.07 |
| Only index persons | 0.04 | 0.02 | 0.05 |
| Median age at first event (years) | |||
| Whole population | - | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 54 | 24 | 30 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
22
102
2.93
3.43
3.2
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
27
145
2.70
3.14
3.6
3.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
5
10.74
3.02
1.8
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
23
118
2.63
2.88
3.4
2.9
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
5
6
8.94
2.79
9.8
5.2
mg/l
1.5
1.3
—
5
6
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
15
5.15
2.68
2.0
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
14
60
2.78
2.43
34.9
15.1
mg/l
1.4
1.0
1.55
14
60
(3004119) Hemoglobin [Mass/volume] in Venous blood
9
28
3.62
2.42
15.3
23.6
g/l
118.4
123.4
—
9
28
(3042936) Bacteria identified in Isolate by Culture
11
41
3.09
2.42
2.2
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
8
6.69
2.41
2.0
1.4
—
—
—
0
0
(3019225) pH of Specimen
5
8
6.69
2.41
5.2
5.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
8
6.69
2.41
4.0
2.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
23
3.87
2.36
2.3
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
13
5.00
2.32
12.8
3.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
30
3.36
2.25
4.1
2.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
147
2.28
2.23
22.2
8.7
mmol/l
1.4
1.1
0.33
19
105
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
31
3.25
2.17
3.9
2.1
—
—
—
0
0
(4035726)
7
20
3.83
2.12
2.4
1.9
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
46
363
2.74
2.10
21.4
9.4
umol/l
58.1
51.7
0.67
46
363
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
21
3.64
2.02
1.9
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
26
161
2.16
2.00
13.0
4.2
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
6
16
4.05
1.98
5.3
5.0
g/mol
41.1
51.0
—
6
16
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
11
4.85
1.97
1.8
3.9
umol/l
26.2
17.1
—
5
11
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
14
67
2.45
1.94
3.4
1.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
8
28
3.15
1.93
11.4
24.1
%
0.8
0.8
—
8
28
(3021901) Oxygen saturation in Capillary blood
5
12
4.44
1.85
14.4
7.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
99
2.21
1.82
6.0
3.6
e6/l
0.3
0.5
0.46
13
55
(3023368) Bacteria identified in Blood by Culture
15
77
2.29
1.78
2.5
3.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
24
3.17
1.77
3.0
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
56
2.45
1.74
3.3
7.9
%
88.6
90.1
0.08
12
56
(36304419) Bacteria [Presence] in Urine
23
142
2.06
1.73
8.5
3.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
25
3.04
1.70
3.0
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
19
3.39
1.70
14.8
18.8
g/l
106.7
123.8
—
6
19
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
18
102
2.13
1.68
5.3
3.8
e6/l
0.7
1.5
0.68
13
58
(3044889) 12 lead EKG panel
7
149
0.39
1.65
3.1
2.2
—
—
—
0
0
(44790047)
6
20
3.22
1.62
3.3
1.5
—
—
—
0
0
(44790048)
6
20
3.22
1.62
3.3
1.5
—
—
—
0
0
(44806118)
6
20
3.22
1.62
3.3
1.5
—
—
—
0
0
(44790049)
6
20
3.22
1.62
3.3
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
15
3.53
1.55
36.0
11.8
mmol/l
23.9
23.0
—
5
15
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
15
3.53
1.55
1.4
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
39
2.54
1.51
4.4
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
24
158
1.91
1.46
5.0
2.8
mmol/l
1.3
1.1
0.77
24
148
(3020393) Adenovirus Ag [Presence] in Stool
5
16
3.31
1.46
1.8
1.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
7
29
2.60
1.43
14.9
24.2
%
98.5
93.4
—
7
29
(3022313) Gas panel - Capillary blood
21
133
1.93
1.43
21.3
8.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
37
0.00
1.41
0.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
17
3.11
1.38
3.0
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
6
25
2.55
1.27
17.2
27.2
%
0.8
0.7
—
6
25
(3014007) Fractional oxyhemoglobin in Arterial blood
6
25
2.55
1.27
17.2
27.4
%
97.7
96.9
—
6
25
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
6
25
2.55
1.27
17.2
27.2
%
0.5
1.0
—
6
25
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
24
165
1.80
1.24
5.5
3.1
mmol/l
2.8
2.5
1.05
24
152
(3011397) Hemoglobin [Presence] in Urine by Test strip
17
106
1.86
1.18
7.5
2.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
20
2.63
1.16
2.2
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
21
141
1.78
1.16
20.9
8.1
mmol/l
24.8
24.1
1.25
21
141
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
21
2.50
1.10
1.6
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
23
162
1.71
1.06
5.6
2.9
mmol/l
1.3
1.4
0.72
23
150
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
22
2.38
1.04
4.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
24
172
1.69
1.04
5.5
3.0
mmol/l
4.4
4.2
0.63
24
161
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
10
54
2.03
1.02
4.3
1.7
—
—
—
0
0
(3015736) pH of Urine
19
129
1.71
0.99
10.4
3.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
19
129
1.71
0.99
1.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
24
174
1.66
0.98
13.3
4.9
e6/l
2.3
18.5
3.91
19
117
(3035637) Corticotropin [Mass/volume] in Plasma
6
28
2.26
0.94
1.7
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
10
56
1.95
0.93
4.1
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
11
65
1.85
0.88
16.7
22.3
mmol/l
0.8
1.2
2.40
11
58
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
24
0.00
0.81
0.0
2.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
24
0.00
0.81
0.0
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
26
0.00
0.80
0.0
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
26
0.00
0.80
0.0
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
9
54
1.78
0.79
12.1
8.7
ng/l
1096.6
1240.6
—
9
46
(40768804) Tissue Pathology biopsy report
9
55
1.75
0.78
1.6
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
23
2.27
0.78
1.2
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
5
24
2.17
0.76
1.2
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
24
2.17
0.76
19.4
26.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5
25
2.08
0.74
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
69
1.73
0.73
4.0
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
14
95
1.62
0.71
12.7
2.7
e6/l
3.1
7.2
1.15
14
81
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
47
426
1.73
0.67
23.0
11.0
mg/l
21.4
22.7
0.10
33
292
(3026782) Osmolality of Urine
13
88
1.61
0.66
6.8
3.1
mosm/kgh2o
428.7
592.4
1.95
13
75
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
19
0.00
0.61
0.0
1.3
—
49.3
—
0
13
(3008898) HLA-B27 [Presence]
0
19
0.00
0.61
0.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
17
127
1.48
0.57
25.8
11.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
9
64
1.47
0.54
1.7
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
6
39
1.59
0.54
1.5
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
13
94
1.49
0.50
4.8
2.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
28
235
1.38
0.49
10.9
3.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
21
168
1.39
0.49
29.9
13.9
mmol/l
24.4
24.9
0.37
21
168
(42870588) Differential panel, method unspecified - Blood
28
236
1.37
0.47
12.8
9.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
8
58
1.43
0.44
2.3
3.1
u/l
315.5
719.9
—
8
58
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
15
0.00
0.42
0.0
3.3
—
5.5
—
0
15
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
16
0.00
0.42
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
75
0.63
0.39
5.4
2.6
—
—
—
0
0
(3012544) pH of Venous blood
17
136
1.35
0.38
22.9
10.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
43
400
1.33
0.28
15.0
7.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
71
0.67
0.28
4.8
2.4
—
—
—
0
0
(3006598) pH of Arterial cord blood
5
69
0.69
0.28
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
6
80
0.71
0.26
15.5
2.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
10
78
1.33
0.25
24.0
5.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
47
444
1.39
0.25
23.7
16.3
%
37.6
38.1
0.23
42
408
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
46
435
1.33
0.24
5.1
3.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
16
135
1.25
0.23
13.5
8.8
mmol/l
23.6
23.4
0.17
16
127
(40768443) Skin Pathology biopsy report
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
6
49
1.24
0.21
1.5
2.5
g/l
0.8
1.0
—
6
49
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
50
1.21
0.20
1.0
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
7
57
1.25
0.19
1.4
1.5
u/ml
39.0
84.7
—
7
57
(36660697) Celiac disease serology panel - Serum
7
84
0.80
0.16
1.0
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
31
288
1.16
0.15
16.5
8.6
e9/l
0.0
0.0
0.71
26
220
(3001604) Monocytes [#/volume] in Blood
31
290
1.14
0.13
16.5
8.6
e9/l
0.7
0.6
0.59
26
221
(3000494) Fungus identified in Specimen by Culture
5
43
1.17
0.10
1.4
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
20
184
1.13
0.10
11.3
6.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
6
56
1.07
0.09
2.3
4.9
g/l
6.7
7.8
—
6
56
(3002030) Lymphocytes/100 leukocytes in Blood
29
302
0.90
0.09
16.7
8.3
%
40.9
38.5
0.38
29
294
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
152
0.88
0.08
1.6
2.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
73
1.10
0.08
1.8
2.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
29
298
0.93
0.04
13.1
9.1
e9/l
0.0
0.0
0.50
23
212
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
17
159
1.09
0.04
16.1
6.6
ml/min/173m2
96.8
110.0
—
10
99
(3022096) Basophils/100 leukocytes in Blood
29
279
1.07
0.03
15.1
8.6
%
0.5
0.6
0.73
29
271
(3013650) Neutrophils [#/volume] in Blood by Automated count
32
312
1.04
0.00
17.2
9.6
e9/l
3.3
3.5
0.25
26
245
(3018010) Neutrophils/100 leukocytes in Blood
29
292
0.97
0.00
15.1
8.2
%
43.9
45.6
0.23
29
284
(3006504) Eosinophils/100 leukocytes in Blood
29
284
1.03
0.00
16.3
8.5
%
3.0
3.3
0.30
29
274
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
22
215
1.03
0.00
1.5
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
11
111
0.98
0.00
16.1
3.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
4.3
—
24.3
—
0
6
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.8
—
30.6
—
0
5
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
7.9
—
8.8
—
0
7
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
98.5
—
0
5
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
6
60
0.99
0.00
1.2
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
67
0.88
0.00
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
20
197
1.01
0.00
1.4
1.9
g/l
1.6
1.3
0.18
11
95
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_INTERSTITIAL_EMPHY_RELATED_COND_ORIGINA_PERINA_PERIOD and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_INTERSTITIAL_EMPHY_RELATED_COND_ORIGINA_PERINA_PERIOD.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_INTERSTITIAL_EMPHY_RELATED_COND_ORIGINA_PERINA_PERIOD – Interstitial emphysema and related conditions originating in the perinatal period
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data